{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:07:53Z","timestamp":1759961273869,"version":"3.37.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jlr.2024.100568","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:20:44Z","timestamp":1716484844000},"page":"100568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of IL-6R blockade on plasma lipids and clinical outcomes among hospitalized patients with COVID-19 infection"],"prefix":"10.1016","volume":"65","author":[{"given":"Kusha","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Sleeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Boyapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parnian","family":"Bigdelou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory P.","family":"Geba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2024.100568_bib1","series-title":"Endotext","article-title":"The effect of inflammation and infection on lipids and lipoproteins","author":"Feingold","year":"2000"},{"key":"10.1016\/j.jlr.2024.100568_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jlr.2024.100568_bib3","series-title":"High density lipoproteins: From biological understanding to clinical exploitation","first-page":"483","article-title":"HDL in infectious diseases and sepsis","author":"Pirillo","year":"2015"},{"key":"10.1016\/j.jlr.2024.100568_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijbiomac.2021.12.009","article-title":"High-density lipoproteins and immune response: a review","volume":"195","author":"Grao-Cruces","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jlr.2024.100568_bib5","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1038\/s41598-021-86747-5","article-title":"Low HDL and high triglycerides predict COVID-19 severity","volume":"11","author":"Masana","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2024.100568_bib6","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","volume":"44","author":"von Eckardstein","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2024.100568_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41423-020-0407-x","article-title":"COVID-19: a new challenge for human beings","volume":"17","author":"Yang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jlr.2024.100568_bib8","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jlr.2024.100568_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2023.101751","article-title":"The bidirectional interaction of COVID-19 infections and lipoproteins","volume":"37","author":"Feingold","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jlr.2024.100568_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.athplu.2021.08.007","article-title":"High-density lipoprotein cholesterol: a marker of COVID-19 infection severity?","volume":"44","author":"Agouridis","year":"2021","journal-title":"Atheroscler. Plus"},{"key":"10.1016\/j.jlr.2024.100568_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacl.2020.04.008","article-title":"Hypolipidemia is associated with the severity of COVID-19","volume":"14","author":"Wei","year":"2020","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2024.100568_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.705916","article-title":"Cholesterol and triglyceride concentrations, COVID-19 severity, and mortality: a systematic review and meta-analysis with meta-regression","volume":"9","author":"Zinellu","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.jlr.2024.100568_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.17219\/acem\/130606","article-title":"The clinical value of high-density lipoprotein in the evaluation of new coronavirus pneumonia","volume":"30","author":"Huang","year":"2021","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.jlr.2024.100568_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cca.2020.07.015","article-title":"Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection","volume":"510","author":"Hu","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jlr.2024.100568_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/17512433.2022.2097905","article-title":"Current status and prospects of IL-6-targeting therapy","volume":"15","author":"Narazaki","year":"2022","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jlr.2024.100568_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in Covid-19: a systematic review and meta-analysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jlr.2024.100568_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jlr.2024.100568_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/14712598.2021.1847269","article-title":"A\u00a0comprehensive review on sarilumab in COVID-19","volume":"21","author":"Khiali","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jlr.2024.100568_bib19","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1093\/cid\/ciac153","article-title":"Efficacy and safety of sarilumab in hospitalized patients with coronavirus disease 2019: a randomized clinical trial","volume":"75","author":"Sivapalasingam","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jlr.2024.100568_bib20","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/infdis\/jiab445","article-title":"Baseline severe acute respiratory syndrome viral load is associated with coronavirus disease 2019 severity and clinical outcomes: post hoc analyses of a phase 2\/3 trial","volume":"224","author":"Boyapati","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jlr.2024.100568_bib21","series-title":"Endotext","article-title":"Lipid and lipoprotein levels in patients with COVID-19 infections","author":"Feingold","year":"2000"},{"key":"10.1016\/j.jlr.2024.100568_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/clinchem\/32.1.142","article-title":"Lipids, lipoproteins, and apoproteins in serum during infection","volume":"32","author":"Alvarez","year":"1986","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jlr.2024.100568_bib23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100568_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.5114\/aoms.2013.34403","article-title":"Distinctive biochemical changes in pulmonary tuberculosis and pneumonia","volume":"9","author":"Sahin","year":"2013","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.jlr.2024.100568_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.hrtlng.2021.01.016","article-title":"The atherogenic index of plasma as a predictor of mortality in patients with COVID-19","volume":"50","author":"Turgay Yildirim","year":"2021","journal-title":"Heart Lung"},{"key":"10.1016\/j.jlr.2024.100568_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbrc.2008.02.023","article-title":"Lipid rafts are involved in SARS-CoV entry into Vero E6 cells","volume":"369","author":"Lu","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jlr.2024.100568_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.micinf.2006.10.015","article-title":"Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle","volume":"9","author":"Li","year":"2007","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jlr.2024.100568_bib28","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jacc.2021.08.021","article-title":"Investigating lipid-Modulating agents for prevention or treatment of COVID-19: JACC state-of-the-Art review","volume":"78","author":"Talasaz","year":"2021","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2024.100568_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101682","article-title":"The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients","volume":"36","author":"Marcello","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.jlr.2024.100568_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1089\/jir.1986.6.655","article-title":"Effects of recombinant interferon-alpha 2 treatment upon lipid concentrations and lipoprotein composition","volume":"6","author":"Massaro","year":"1986","journal-title":"J.\u00a0Interferon Res."},{"key":"10.1016\/j.jlr.2024.100568_bib31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/cells10051061","article-title":"HDL in immune-inflammatory responses: implications beyond cardiovascular diseases","volume":"10","author":"Bonacina","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jlr.2024.100568_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/MOL.0000000000000577","article-title":"Molecular regulation of plasma lipid levels during systemic inflammation and sepsis","volume":"30","author":"Trinder","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jlr.2024.100568_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315350","article-title":"Dyslipidemia and inflammation as hallmarks of oxidative stress in COVID-19: a follow-up study","volume":"23","author":"Aparisi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2024.100568_bib34","article-title":"Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications","volume":"1866","author":"Ko\u010dar","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jlr.2024.100568_bib35","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.ATV.20.7.1777","article-title":"Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements","volume":"20","author":"Gierens","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2024.100568_bib36","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.intimp.2008.07.002","article-title":"Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production","volume":"8","author":"Uchiyama","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jlr.2024.100568_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S2213-8587(22)00355-2","article-title":"Risks and burdens of incident dyslipidaemia in long COVID: a cohort study","volume":"11","author":"Xu","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jlr.2024.100568_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-hospital Use of statins is associated with a reduced risk of mortality among individuals with COVID-19","volume":"32","author":"Zhang","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2024.100568_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.amjms.2021.03.001","article-title":"Association of pre-admission statin use with reduced in-hospital mortality in COVID-19","volume":"361","author":"Chacko","year":"2021","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jlr.2024.100568_bib40","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5114\/aoms.2020.94655","article-title":"Statins and the COVID-19 main protease: in silico evidence on direct interaction","volume":"16","author":"Reiner","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.jlr.2024.100568_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12944-023-01828-w","article-title":"Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Khalaji","year":"2023","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jlr.2024.100568_bib42","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1056\/NEJMoa2309995","article-title":"Simvastatin in critically ill patients with Covid-19","volume":"389","author":"Hills","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2024.100568_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12931-024-02732-2","article-title":"Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial","volume":"25","author":"Eltahan","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.jlr.2024.100568_bib44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jacc.2022.10.030","article-title":"PCSK9 inhibition during the inflammatory stage of SARS-CoV-2 infection","volume":"81","author":"Navarese","year":"2023","journal-title":"J.\u00a0Am. Coll. Cardiol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524000737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524000737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T05:03:28Z","timestamp":1719551008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227524000737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0022227524000737"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100568","relation":{},"ISSN":["0022-2275"],"issn-type":[{"type":"print","value":"0022-2275"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of IL-6R blockade on plasma lipids and clinical outcomes among hospitalized patients with COVID-19 infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100568"}}